Institut Bergonié
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1923-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.bergonie.org
STUDY OF THE EXPRESSION OF CIRCULATING AND INTRA-TUMORAL CHEMOKINES IN PATIENTS WITH PROSTATE CANCER
- Conditions
- Interventions
- First Posted Date
- 2016-08-16
- Last Posted Date
- 2016-08-17
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 145
- Registration Number
- NCT02869282
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
Regional Central Database Recording of Chronic Myeloid Leukemia
- Conditions
- First Posted Date
- 2016-08-16
- Last Posted Date
- 2017-11-21
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 400
- Registration Number
- NCT02869256
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷Centre Hospitalier Universitaire de Pau, Pau, France
🇫🇷Polyclinique Bordeaux Nord, Bordeaux, France
Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer
- First Posted Date
- 2016-07-04
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 346
- Registration Number
- NCT02821793
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound
- Conditions
- Interventions
- First Posted Date
- 2016-06-30
- Last Posted Date
- 2017-11-21
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 106
- Registration Number
- NCT02819362
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide
Phase 1
Completed
- Conditions
- First Posted Date
- 2016-06-20
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 50
- Registration Number
- NCT02805725
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-06-08
- Last Posted Date
- 2021-04-21
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 11
- Registration Number
- NCT02792959
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, Gironde, France
CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.
- First Posted Date
- 2016-06-03
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 205
- Registration Number
- NCT02789384
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷Institut Claudius Regaud - IUCT-0, Toulouse Cedex 9, France
🇫🇷Centre Oscar Lambret, Lille Cedex, France
A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-06-01
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 41
- Registration Number
- NCT02787642
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷Centre Léon Bérard, Lyon, France
🇫🇷Institut du Cancer de Montpellier, Montpellier, France
Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer
- First Posted Date
- 2016-05-17
- Last Posted Date
- 2017-10-06
- Lead Sponsor
- Institut Bergonié
- Registration Number
- NCT02774512
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
Predicting Severe Toxicity of Targeted Therapies in Elderly Patients With Cancer
- First Posted Date
- 2016-04-26
- Last Posted Date
- 2021-06-25
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 312
- Registration Number
- NCT02751827
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷Centre Léon Bérard, Lyon Cedex 08, France
© Copyright 2024. All Rights Reserved by MedPath